Ethnic inequalities in cancer survival in New Zealand: linkage study.

Changing trends in indigenous inequalities in mortality: lessons from New Zealand.

BACKGROUND We describe trends from 1951 to 2006 in inequalities in mortality between the indigenous (Māori) and non-indigenous (non-Māori, mainly European-descended) populations of New Zealand. We relate these trends to the historical context in which they occurred, including major structural adjustment of the economy from the mid 1980s to the mid 1990s, followed by a retreat from neoliberal so...

Trends in ethnic and socioeconomic inequalities in cancer survival, New Zealand, 1991-2004.

Improvements in cancer survival may be distributed inequitably throughout populations and across time. We assessed trends in cancer survival inequalities in New Zealand by ethnic and income group. 126,477 people diagnosed with cancer between 1991 and 2004, followed-up to 2006, were included. First, inequalities pooled over time were measured with excess mortality rate ratios (EMRRs). Second, in...

Author's response to reviews Title: Does comorbidity explain the ethnic inequalities in cervical cancer survival in New Zealand? A retrospective cohort study Authors:

Improving survival disparities in cervical cancer between Māori and non-Māori women in New Zealand: a national retrospective cohort study.

OBJECTIVE Māori women in New Zealand have higher incidence of and mortality from cervical cancer than non-Māori women, however limited research has examined differences in treatment and survival between these groups. This study aims to determine if ethnic disparities in treatment and survival exist among a cohort of Māori and non-Māori women with cervical cancer. METHODS A retrospective cohor...

Which factors account for the ethnic inequalities in stage at diagnosis and cervical cancer survival in New Zealand?

OBJECTIVE There are substantial ethnic inequalities in stage at diagnosis and cervical cancer survival in New Zealand. We assessed what proportions of these differences were due to screening history (for the analyses of late stage diagnosis), stage at diagnosis (for the analyses of survival), comorbid conditions (for the analyses of survival), and travel time to the nearest General Practitioner...